Michael Mortensen

Director de Operaciones en BONESUPPORT HOLDING AB .

Fortuna: 576 536 $ al 30/04/2024

Consumer Services

Health Technology

Cargos activos de Michael Mortensen

Empresas	Cargo	Inicio	Fin
BONESUPPORT HOLDING AB	Director de Operaciones	01/12/2021	-
BONESUPPORT HOLDING AB	Director Técnico/Científico/I+D	01/12/2021	-
Nanovi Radiotherapy A/S Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark.	Corporate Officer/Principal	-	-

University of Copenhagen	Doctorate Degree
Technical University of Denmark	Graduate Degree
AVT Business School A/S	Masters Business Admin

Internacional

Dinamarca	5
Suecia	2

Operativa

Sectorial

Consumer Services	4
Health Technology	3

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	1
BONESUPPORT HOLDING AB	Health Technology

Empresas privadas	1
Nanovi Radiotherapy A/S Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark.	Health Technology

Empresas privadas

Health Technology